Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
This study is ongoing, but not recruiting participants.
Study NCT01561014
Information provided by Comprehensive Cancer Center of Wake Forest University
First Received on February 14, 2012.
Last Updated on May 3, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
